X hits on this document

71 views

0 shares

0 downloads

0 comments

8 / 28

University, 1989-1990

Project Director, "National Reference Center for Bioethics

Literature," $1,220,000 grant, National Library of Medicine, 1990-1994

Member, Editorial Board, Human Gene Therapy, 1990-present

Project Director, "Support for the BIOETHICSLINE Database,"$987,240 contract, National Library of Medicine, 1991-1994

Member, Data and Safety Monitoring Committee, Global

Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO I), 1991-1993

Member, Recombinant DNA Advisory Committee, National

Institutes of Health, 1992-1996

Principal Investigator, "National Information Resource on Ethics and Human Genetics," $100,000 grant, National Center for Human Genome Research, 1992-1994

Chair, Recombinant DNA Advisory Committee, National Institutes of Health, 1993-1996

Chair, Advisory Panel, Project on "The Human Genome Project and Patenting Human Sequences," Office of Technology Assessment, U.S. Congress, 1993-1994

Member, Data and Safety Monitoring Board, Thymopentin Trial, Weinberg Consulting Group, Washington, D.C., for Immunobiology Research Institute, Annandale, NJ, 1993-1996

Member, Safety Review Board, Procysteine Trial, In Vivo,

Inc., Princeton, NJ, and Free Radical Sciences, Inc., Deerfield, IL, 1993

Member, Data and Safety Monitoring Board, Global Use of

Strategies to Open Occluded Arteries in Acute Coronary Syndrome (GUSTO IIa and IIb), 1993-1995

Member, Data Review Committee, 3TC Trial, Glaxo, Inc.,

Research Triangle, NC, 1993-1995

Document info
Document views71
Page views71
Page last viewedWed Dec 07 08:58:23 UTC 2016
Pages28
Paragraphs535
Words5720

Comments